CLINICAL_TRIALS trial_result · 2019-12-17

Clinical Trial Update: A Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501) [Phase 2]

Phase 2 trial evaluating a steroid-free treatment for standard-risk acute graft-versus-host disease has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Medical College of Wisconsin | Conditions: Acute GVHD | Phase 2 | Status: COMPLETED | Results posted: 2019-12-17